BOSTON, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) provided a business update on the abaloparatide global business. Progress was made, and continues to be made, across the following areas.

Here is the original post:
Radius Health, Inc. Provides Abaloparatide Business Update

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh